|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 101.36 USD | -0.62% |
|
-3.77% | +26.89% |
Business description: Medtronic plc
- general and minimally invasive surgery (25%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.;
- cardiac rhythm management (19%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.;
- vascular diseases and cardiac surgery (18.1%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.;
- cranial and spinal technologies (14.8%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity;
- neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.7%);
- diabetes management (8.2%): internal and external glycemia monitoring systems and insulin pumps;
- neurological disorders (5.7%): neurostimulation and pumped medication administration products, diagnostic tools, etc. ;
- other (0.5%).
Net sales are distributed geographically as follows: Ireland (0.3%), the United States (51.2%) and other (48.5%).
Number of employees: 95,000
Sales by Activity: Medtronic plc
| Fiscal Period: April | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
Cardiovascular | 1.08TCr | 1.14TCr | 1.16TCr | 1.18TCr | 1.25TCr |
Neuroscience | 819.5Cr | 878.4Cr | 895.9Cr | 940.6Cr | 984.6Cr |
Medical Surgical | 873.7Cr | 914.1Cr | 843.3Cr | 841.7Cr | 840.7Cr |
Diabetes | 241.3Cr | 233.8Cr | 226.2Cr | 248.8Cr | 275.5Cr |
Other | - | - | - | 22Cr | 14Cr |
Unallocated Other Adjustments | - | - | - | - | -9Cr |
Geographical breakdown of sales: Medtronic plc
| Fiscal Period: April | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
United States | 1.55TCr | 1.61TCr | 1.64TCr | 1.66TCr | 1.72TCr |
Rest of World | 1.45TCr | 1.54TCr | 1.48TCr | 1.57TCr | 1.62TCr |
Ireland | 10Cr | 10Cr | 9.8Cr | 11Cr | 12Cr |
Executive Committee: Medtronic plc
| Manager | Title | Age | Since |
|---|---|---|---|
Geoffrey Martha
CEO | Chief Executive Officer | 55 | 27/04/2020 |
Thierry Pieton
DFI | Director of Finance/CFO | 55 | 03/03/2025 |
Laura Mauri
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2020 |
| Investor Relations Contact | - | 01/08/2009 | |
Michelle Quinn
LAW | General Counsel | 57 | 01/07/2025 |
Composition of the Board of Directors: Medtronic plc
| Director | Title | Age | Since |
|---|---|---|---|
Craig Arnold
BRD | Director/Board Member | 65 | 26/01/2015 |
Scott Donnelly
BRD | Director/Board Member | 63 | 01/01/2013 |
Randall Hogan
BRD | Director/Board Member | 69 | 01/01/2015 |
Elizabeth Nabel
BRD | Director/Board Member | 73 | 01/01/2014 |
Geoffrey Martha
CHM | Chairman | 55 | 11/12/2020 |
Kendall Powell
BRD | Director/Board Member | 71 | 01/01/2007 |
Kevin Lofton
BRD | Director/Board Member | 70 | 15/09/2020 |
Lidia Fonseca
BRD | Director/Board Member | 56 | 27/06/2022 |
Gregory Lewis
BRD | Director/Board Member | 57 | 26/06/2023 |
Joon Sup Lee
BRD | Director/Board Member | 63 | 18/06/2025 |
Holdings: Medtronic plc
| Name | Equities | % | Valuation |
|---|---|---|---|
| 58,68,916 | 10.39% | 2,28,88,772 $ |
Company details: Medtronic plc

Group companies: Medtronic plc
| Name | Category and Sector |
|---|---|
Medtronic Engineering & Innovation Center Pvt Ltd.
Medtronic Engineering & Innovation Center Pvt Ltd. Provides healthcare technology services | |
Medtronic Defined Contribution Plan Master Trust
Medtronic Defined Contribution Plan Master Trust Provides trust services | |
India Medtronic Pvt Ltd.
India Medtronic Pvt Ltd. Engages in the medical technology | |
India Medtronic Pvt Ltd.
India Medtronic Pvt Ltd. Engages in the medical technology | |
Medtronic Holding Hungary Kft. |
Other Medical Equipment, Supplies & Distribution
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.62% | -3.77% | +20.65% | +31.50% | 13TCr | ||
| -0.26% | -2.96% | +8.20% | +20.43% | 22TCr | ||
| +0.60% | -7.93% | +39.54% | +100.60% | 6.59TCr | ||
| +0.10% | -0.03% | -11.84% | -20.64% | 5.54TCr | ||
| +0.25% | +1.92% | +17.82% | +76.38% | 5.2TCr | ||
| +0.87% | -1.13% | +21.95% | +43.42% | 2.58TCr | ||
| +0.37% | +3.18% | -15.74% | -43.94% | 2.55TCr | ||
| -0.33% | +2.89% | +18.63% | -34.55% | 2.41TCr | ||
| -2.23% | -2.91% | -23.08% | +19.35% | 2.25TCr | ||
| -3.62% | -6.94% | +14.70% | +1.51% | 2.14TCr | ||
| Average | -0.49% | -1.77% | +9.08% | +19.41% | 6.4TCr | |
| Weighted average by Cap. | -0.29% | -2.58% | +12.11% | +27.54% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MDT Stock
- Company Medtronic plc
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















